Wright Mary E 4
4 · Inogen Inc · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Inogen (INGN) VP/Chief Accounting Officer Mary Wright Exercises Options and Receives Awards
What Happened
Mary E. Wright, VP and Chief Accounting Officer of Inogen (INGN), had multiple equity events that vested/converted into shares and completed an ESPP purchase. The filing shows 18,357 shares acquired (including vested/converted restricted stock units and a 1,500-share Employee Stock Purchase Plan purchase at $6.10 for $9,150) and 10,914 shares disposed in connection with withholding/settlement, leaving a net increase of 7,443 shares. Tax-withheld shares totaled 3,408 shares sold at $6.10 per share, generating about $20,790.
Key Details
- Transaction dates: grants/vesting and conversions on Feb 27, 2026 and March 1, 2026; Form 4 filed March 3, 2026 (appears timely).
- Prices and values: ESPP purchase — 1,500 shares at $6.10 = $9,150. Withheld shares for taxes — 3,408 shares at $6.10 ≈ $20,790. Many RSU conversions/exercises reported at $0 (typical for vested RSUs).
- Aggregate movement: 18,357 shares acquired (includes an 8,000-share performance RSU grant) and 10,914 shares disposed; net change +7,443 shares.
- Notable footnotes:
- F1: ESPP purchase shares were acquired through the Company’s ESPP.
- F2 & F4: Certain shares were withheld to satisfy tax withholding on vesting.
- F3 & F7: The 8,000 performance-based RSUs were earned/vested (performance condition met) and fully vested on March 1, 2026.
- F5: Each RSU converts to one share. F6/F8/F9 describe remaining/time-based vesting schedules for other awards.
- Shares owned after transaction: not reported in the supplied data.
Context
Most of these transactions are vesting/conversion of restricted stock units (derivative conversions reported at $0) and the routine ESPP purchase. Several converted RSUs were either settled into shares or immediately withheld/surrendered to cover tax obligations (a common, administrative “cashless” settlement). These filings document issuance/settlement and tax withholding rather than open-market market sales by the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-01$6.10/sh+1,500$9,150→ 13,680 total - Exercise/Conversion
Common Stock
2026-03-01+1,755→ 15,435 total - Tax Payment
Common Stock
[F2]2026-03-01$6.10/sh−675$4,118→ 14,760 total - Award
Common Stock
[F3]2026-03-01+1,351→ 16,111 total - Tax Payment
Common Stock
[F4]2026-03-01$6.10/sh−520$3,172→ 15,591 total - Exercise/Conversion
Common Stock
2026-03-01+2,750→ 18,341 total - Tax Payment
Common Stock
[F2]2026-03-01$6.10/sh−1,058$6,454→ 17,283 total - Exercise/Conversion
Common Stock
2026-03-01+3,001→ 20,284 total - Tax Payment
Common Stock
[F2]2026-03-01$6.10/sh−1,155$7,046→ 19,129 total - Award
Restricted Stock Unit
[F5][F6]2026-02-27+8,000→ 8,000 total→ Common Stock (8,000 underlying) - Exercise/Conversion
Restricted Stock Unit
[F5][F7]2026-03-01−1,755→ 0 total→ Common Stock (1,755 underlying) - Exercise/Conversion
Restricted Stock Unit
[F5][F8]2026-03-01−2,750→ 2,749 total→ Common Stock (2,750 underlying) - Exercise/Conversion
Restricted Stock Unit
[F5][F9]2026-03-01−3,001→ 6,002 total→ Common Stock (3,001 underlying)
Footnotes (9)
- [F1]Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
- [F2]The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2026.
- [F3]The reported securities represent shares earned and vested on March 1, 2026 based on achievement of the financial performance conditions for the 2025 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on February 28, 2023.
- [F4]The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on February 28, 2023 and vested on March 1, 2026.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F6]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
- [F7]The restriced stock units were fully vested on March 1, 2026.
- [F8]1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.
- [F9]1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.